SAMSUNG BIOLOGICS CO.,LTD.

207940 KRX Pharmaceuticals Pharmaceuticals
KOSPI

Shareholding pattern

As reported to FSS/DART, 2025-12-31.

Largest shareholder group74.32%
Minority shareholders21.72%
Top 10 holders74.32%
Total shareholders85,841

Who owns the company

Share of shares outstanding
Largest shareholder & related parties: 74.32%Minority shareholders: 21.72%Institutions & other holders: 3.96%74.3%Largest shareholder & related parties
Largest shareholder & related parties 74.32%Minority shareholders 21.72%Institutions & other holders 3.96%

How to read this: the largest shareholder group is the controlling owner and related parties — a big slice means tight control. Minority shareholders are the many small holders. The remainder is mostly institutional and foreign money, which the regulator does not itemise separately.

Ownership detail

Investor categoryHolding %Shareholders
Largest shareholder & related parties74.32%
Minority shareholders21.72%85,805
Institutions & other holders3.96%

How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.

Largest shareholders

S.No.ShareholderSharesStake %
1삼성물산19,932,35043.06%
2삼성전자14,449,94431.22%
3삼성생명보험(특별계정)19,6390.04%
4존림 (Rim John Chongbo)2600.00%
5유승호1300.00%
6노균600.00%

Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.

Educational data only. Not a recommendation to buy, sell or hold any security.